SPRBNasdaqPharmaceutical Preparations

Spruce Biosciences, Inc. (SPRB) earnings date, market-implied expected move, and options open interest by expiry

44.90

+2.09 · +4.88%

Regular session15:27 ET

Open40.00Volume73,491Mkt cap$123.0MEPS-21.12

Day40.00 – 45.5888%52-wk38.06 – 129.008%

SPRB

Spruce Biosciences, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 9

after close · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

+1.42%

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Linked news

23hBMRN · supplierBioMarin nine-month net income $27,458; total revenues $2,780,562; Q3 net loss $122,831
6dLLY · supplierWe're raising our price target on Eli Lilly as the obesity-drug boom rolls on

News

Largest filed tie

13F top-10 QoQ

—

Top fund weight

0.00%

SPRB weight · IWM

N-PORTJun 30 '26

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Spruce Biosciences (SPRB) is expected to report on Nov 9 after close (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 12 '26confirmed—▲+1.42%—

quarterimplied−5%0+5%realized×

Q2 FY26—▲+1.42%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 1 expiry · May 22 close

—OI · 1 expiry · May 22 closeP/C open interest · Dec 18 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

0—Dec 1844d0—

ExpiryPutsCallsP/C

Dec 1844d0—0——

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

derived from FYQ4 FY24

−3380.06%derived from FYnet margin · revenue +15.78% QoQ · −75.86% YoY

Revenue$697,000+15.78%

Gross profit$697,000100.00%+15.78%

Operating income−$24M−3453.95%−155.89%

Pre-tax income−$24M−171.70%

Net income−$24M−3380.06%−171.70%

Operating expenses$25M+147.46%

Other income$515,000−30.12%

Derived: FY − Q1–Q3 · QE Dec 31 '24 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:15 ET

Intraday

Event sensitivity

CPI ×0.29· ±4.3% vs ±15.0% · 10 releases

eventrelease day|move|up · n×base

CPIconsumer prices±4.3%5 of 10×0.29

PPIproducer prices±4.3%4 of 10×0.28

PCEpersonal income & outlays±3.7%10 of 18×0.25

GDPgross domestic product±3.5%8 of 18×0.23

CPROFcorporate profits±3.4%6 of 11×0.23

FOMCrate decision±3.0%7 of 24×0.20

NFPjobs report±2.6%5 of 10×0.17

Bar = avg |move| to ±16% · tick = ±15.0% avg day · ×base = |move| ÷ ±15.0% · min 6 releases

Earnings history

EPS -6.68 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-6.68	—
Q1 FY26	—	-8.94	—
Q3 FY25	—	-14.58	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod